本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Immunocore Holdings plc

30.43
+1.725.99%
盘前31.390.9600+3.15%04:23 EDT
成交量:55.13万
成交额:1,670.59万
市值:15.24亿
市盈率:-29.78
高:31.64
开:29.60
低:29.21
收:28.71
数据加载中...
2022/09/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/07/21

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/07/20

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/17

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/03

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/18

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/10/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/20

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/04/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/12

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/25

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals